Loomis, Sayles & Company Portfolio holdings
AUM
$79.8B
This Quarter Return
-11.68%
1 Year Return
+31.99%
3 Year Return
+166.63%
5 Year Return
+219.21%
10 Year Return
+619.03%
AUM
$48.5B
AUM Growth
+$48.5B
(-17%)
Cap. Flow
-$1.8B
Cap. Flow
% of AUM
-3.72%
Top 10 Holdings %
Top 10 Hldgs %
41.47%
Holding
822
New
91
Increased
235
Reduced
364
Closed
101
Top Buys
| 1 |
Salesforce
CRM
|
$986M |
| 2 |
Boeing
BA
|
$470M |
| 3 |
Workday
WDAY
|
$378M |
| 4 |
Illumina
ILMN
|
$320M |
| 5 |
Intuitive Surgical
ISRG
|
$110M |
Top Sells
| 1 |
Coca-Cola
KO
|
$909M |
| 2 |
Procter & Gamble
PG
|
$545M |
| 3 |
Novo Nordisk
NVO
|
$321M |
| 4 |
Qualcomm
QCOM
|
$317M |
| 5 |
Amazon
AMZN
|
$184M |
Sector Composition
| 1 | Technology | 24.39% |
| 2 | Consumer Discretionary | 17.07% |
| 3 | Healthcare | 16.2% |
| 4 | Communication Services | 11.46% |
| 5 | Financials | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Ares Management
ARES
$39.3B
| $20.3M | 0.04% | 656,983 -7,238 | -1% | -$224K |
|
152
First American
FAF
$6.72B
| $20.1M | 0.04% | 474,592 +199,952 | +73% | +$8.48M |
|
153
Ciena
CIEN
$13.3B
| $20M | 0.04% | 502,752 +27,416 | +6% | +$1.09M |
|
154
National Vision
EYE
$1.82B
| $19.8M | 0.04% | 1,021,796 -94,797 | -8% | -$1.84M |
|
155
UFP Industries
UFPI
$5.91B
| $19.7M | 0.04% | 528,818 +163,298 | +45% | +$6.07M |
|
|
EPZM
156
DELISTED
Epizyme, Inc
EPZM
| $19.6M | 0.04% | 1,266,544 -334,749 | -21% | -$5.19M |
|
157
Baidu
BIDU
$32.8B
| $19.6M | 0.04% | 194,841 -3,685 | -2% | -$371K |
|
158
West Pharmaceutical
WST
$17.8B
| $19.6M | 0.04% | 128,983 -1,423 | -1% | -$217K |
|
159
PTC Therapeutics
PTCT
$3.92B
| $19.6M | 0.04% | 439,151 +2,666 | +0.6% | +$119K |
|
160
Natera
NTRA
$23.1B
| $19.5M | 0.04% | +651,481 | New | +$19.5M |
|
|
RETA
161
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $19.3M | 0.04% | 133,889 +17,909 | +15% | +$2.59M |
|
|
NUVA
162
DELISTED
NuVasive, Inc.
NUVA
| $19.3M | 0.04% | +380,356 | New | +$19.3M |
|
163
Post Holdings
POST
$6.15B
| $19.2M | 0.04% | 231,188 -3,472 | -1% | -$288K |
|
164
Vistra
VST
$64.1B
| $19.1M | 0.04% | 1,193,891 +46,999 | +4% | +$750K |
|
165
Inspire Medical Systems
INSP
$2.77B
| $18.9M | 0.04% | 313,610 +39,819 | +15% | +$2.4M |
|
166
Frontdoor
FTDR
$4.43B
| $18.9M | 0.04% | 543,070 +428,509 | +374% | +$14.9M |
|
167
Rambus
RMBS
$7.94B
| $18.5M | 0.04% | 1,666,504 +231,187 | +16% | +$2.57M |
|
168
Prosperity Bancshares
PB
$6.57B
| $18.5M | 0.04% | 382,476 -7,361 | -2% | -$355K |
|
169
Y-mAbs Therapeutics
YMAB
$388M
| $18.5M | 0.04% | 706,915 +161,859 | +30% | +$4.22M |
|
170
Churchill Downs
CHDN
$7.27B
| $18.3M | 0.04% | 177,440 -24,234 | -12% | -$2.49M |
|
|
XIFR
171
XPLR Infrastructure, LP
XIFR
$996M
| $18.1M | 0.04% | 419,918 +12,924 | +3% | +$556K |
|
172
Ziff Davis
ZD
$1.57B
| $18M | 0.04% | 240,149 +15,806 | +7% | +$1.18M |
|
173
WEX
WEX
$5.87B
| $17.9M | 0.04% | 170,969 -102,031 | -37% | -$10.7M |
|
174
Chemed
CHE
$6.67B
| $17.7M | 0.04% | 40,888 +2,573 | +7% | +$1.11M |
|
175
Veracyte
VCYT
$2.39B
| $17.6M | 0.04% | +724,273 | New | +$17.6M |
|